|
1
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004.
|
|
2
|
Lorin S, Hamaï A, Mehrpour M and Codogno
P: Autophagy regulation and its role in cancer. Semin Cancer Biol.
23:361–379. 2013.
|
|
3
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008.
|
|
4
|
Levine B and Yuan J: Autophagy in cell
death: an innocent convict? J Clin Invest. 115:2679–2688. 2005.
|
|
5
|
Klionsky DJ, Abeliovich H, Agostinis P, et
al: Guidelines for the use and interpretation of assays for
monitoring autophagy in higher eukaryotes. Autophagy. 4:151–175.
2008.
|
|
6
|
Hsieh MJ, Tsai TL, Hsieh YS, et al:
Dioscin-induced autophagy mitigates cell apoptosis through
modulation of PI3K/Akt and ERK and JNK signaling pathways in human
lung cancer cell lines. Arch Toxicol. 87:1927–1937. 2013.
|
|
7
|
Prasad R, Vaid M and Katiyar SK: Grape
proanthocyanidin inhibit pancreatic cancer cell growth in vitro and
in vivo through induction of apoptosis and by targeting the
PI3K/Akt pathway. PLoS One. 7:e430642012.
|
|
8
|
Wang CY, Bai XY and Wang CH: Traditional
chinese medicine: a treasured natural resource of anticancer drug
research and development. Am J Chin Med. 42:543–559. 2014.
|
|
9
|
Liu Z, Chen S, Cai J, et al: Traditional
Chinese medicine syndrome-related herbal prescriptions in treatment
of malignant tumors. J Tradit Chin Med. 33:19–26. 2913.
|
|
10
|
Gong K and Li W: Shikonin, a Chinese
plant-derived naphthoquinone, induces apoptosis in hepatocellular
carcinoma cells through reactive oxygen species: A potential new
treatment for hepatocellular carcinoma. Free Radic Biol Med.
51:2259–2271. 2011.
|
|
11
|
Yao Y and Zhou Q: A novel antiestrogen
agent Shikonin inhibits estrogen-dependent gene transcription in
human breast cancer cells. Breast Cancer Res Treat. 121:233–240.
2010.
|
|
12
|
Wiench B, Eichhorn T, Paulsen M and
Efferth T: Shikonin directly targets mitochondria and causes
mitochondrial dysfunction in cancer cells. Evid Based Complement
Alternat Med. 2012:7260252012.
|
|
13
|
Sabater L, Calvete J, Aparisi L, et al:
Pancreatic and periampullary tumors: morbidity, mortality,
functional results and long-term survival. Cir Esp. 86:159–166.
2009.(In Spanish).
|
|
14
|
Yue Z, Jin S, Yang C, et al: Beclin 1, an
autophagy gene essential for early embryonic development, is a
haploinsufficient tumor suppressor. Proc Natl Acad Sci USA.
100:15077–15082. 2003.
|
|
15
|
Yang ZJ, Chee CE, Huang S and Sinicrope F:
Autophagy modulation for cancer therapy. Cancer Biol Ther.
11:169–176. 2011.
|
|
16
|
Bjørkøy G, Lamark T, Brech A, et al:
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a
protective effect on huntingtin-induced cell death. J Cell Biol.
171:603–614. 2005.
|
|
17
|
Martelli AM, Evangelisti C, Follo MY, et
al: Targeting the phosphatidylinositol 3-kinase/Akt/mammalian
target of rapamycin signaling network in cancer stem cells. Curr
Med Chem. 18:2715–2726. 2011.
|
|
18
|
Singh BN, Kumar D, Shankar S and
Srivastava RK: Rottlerin induces autophagy which leads to apoptotic
cell death through inhibition of PI3K/Akt/mTOR pathway in human
pancreatic cancer stem cells. Biochem Pharmacol. 84:1154–1163.
2012.
|
|
19
|
Wu H, Xie J, Pan Q, et al: Anticancer
agent shikonin is an incompetent inducer of cancer drug resistance.
PLoS One. 8:e527062013.
|
|
20
|
Yang H, Zhou P, Huang H, et al: Shikonin
exerts antitumor activity via proteasome inhibition and cell death
induction in vitro and in vivo. Int J Cancer. 124:2450–2459.
2009.
|
